Healthcare Contract Development and Manufacturing Organization Market

Healthcare Contract Development and Manufacturing Organization Market by Service (Contract Development, Contract Manufacturing) and by Region (North America, Latin America, Europe, APAC, MEA) - 2022 to 2032

Newly-released Healthcare Contract Development and Manufacturing Organization market analysis report by Transparency Market Research shows that global sales of the market for Healthcare Contract Development and Manufacturing Organization in 2021 was held at US$ 221.1 Bn. With an 11.6% CAGR during 2022 - 2032, the projected market growth is expected to reach a valuation of US$ 723.6 Bn. The absolute dollar opportunity for the Healthcare CDMO market will be US$ 479.6 Bn during 2022 – 2032.

Revenue of the Healthcare Contract Development and Manufacturing Organization (CDMO) market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the Healthcare Contract Development and Manufacturing Organization market research by Transparency Market Research - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Healthcare Contract Development and Manufacturing Organization (CDMO) market increased at around 9.8% CAGR. Countries such as the U.S., China, Japan, the U.K., and South Korea held a significant share of the global market.

Healthcare contract development and manufacturing organizations render outsourcing services to several pharmaceutical industries on a contract basis. To reduce operational and capital expenses, the pharmaceutical industries look for healthcare contract development and manufacturing organizations to a large extent. Owing to this, Contract Development and Manufacturing Organization market is projected to grow at a CAGR of 11.6% over the coming 10 years.

What will be the growth prospects of the Healthcare Contract Development and Manufacturing Organization Market?

Regulations regarding the synthesis and development of generic medicine and biologics have created a significant demand for medical services and the need for various manufacturing procedures. This has also motivated many pharmaceutical companies to approach healthcare organizations and healthcare organizations to sustain the supply and demand for medical activities.

The biopharmaceuticals, medical operations, and devices found in the pharma industries led to increased complexity in operations and the supply chain that make companies more likely to contract manufacture and develop. In March of 2021, Fujifilm Diosynth Biotechnologies selected Holly Springs, North Carolina, for its new site with a ¥200-billion capacity.

Which Region is projected to Offer the Largest Opportunity for Healthcare CDMO Market?

With over 13.6% and 13.2% projected growth rates in Japan and China respectively, Healthcare Contract Development and Manufacturing Organization market revenue are expected to grow at the fastest pace in the Asia Pacific, during 2022 - 2032. Some of the key companies having manufacturing units at prominent locations in APAC have started to expand their production units to different locations of APAC to distribution efficiency. While this implies a shift in the diversification of global locations, it promises a significant opportunity for the global market.

Country-wise Analysis

U.S. Healthcare Contract Development and Manufacturing Organization (CDMO) Market Analysis

The US dominated the global Healthcare CDMO market and is poised to reach US$ 275.6 Bn by 2032. The growing number of hospital admission and ease of medicare reimbursement policy drives the demand for medical drugs and activities to a significant extent, thus to meet the requirement in the stipulated time the companies approach the CDMO.

U.K. Healthcare Contract Development and Manufacturing Organization Market Analysis

The Healthcare CDMO Market in the U.K. stood at US$ 8.5 Bn in 2021. The market is projected to reach a valuation of US$ 24.2 Bn by 2032. The market in the country is expected to gross an absolute dollar opportunity of US$ 14.9 Bn during 2022 – 2032, growing at a CAGR of 10%.

Japan Healthcare CDMO Market Analysis

The Healthcare CDMO Market in Japan is estimated at US$ 9.5 Bn in 2022. The market is projected to reach a valuation of US$ 34.2 Bn by 2032. With a projected CAGR of 13.6% during 2022 – 2032, the market is projected to score an absolute dollar opportunity of US$ 24.6 Bn.

South Korea Healthcare Contract Development and Manufacturing Organization Market Analysis

The market for Healthcare CDMO in South Korea is expected to garner a market size of US$ 22.8 Bn by 2032, growing at a CAGR of 13.7% during 2022 – 2032. During this period, the market is expected to garner an absolute dollar opportunity of US$ 16.4 Bn.

Category-wise Insights

Which Services of Healthcare Contract Development and Manufacturing Organizations are in High demand?

Pharmaceutical and medical device manufacturers plan to outsource to reduce manufacturing expenses. It enables manufacturers to be more dynamic and cost-effective in their manufacturing procedures, allowing for the development of new medical drugs and devices. These materials were used as a result of recent and minimally invasive surgical procedures. The rapid surge in demand will be met by outsourcing manufacturing activities.

COVID-19 pushed companies to increase the manufacturing of drugs and devices. The US FDA statistics show that 60% of the medical manufacturing activities are coming from China to meet the demand for drugs in the stipulated time. However, during the pandemic, the supply chain of China's medical manufacturing activities was totally disrupted.

The shortage created a demand for the manufacturing of active pharmaceutical ingredients (APIs) in order to maintain supply. Based on a 2020 Global Managed Services Report, nearly 45% of organizations will outsource more in the coming years. The sub-services of contract manufacturing are Small molecules, Large Molecules, High Potency API, Finished Dose Formulations, and Medical Devices.

Why have sub-services like medical devices in Contract Manufacturing Organizations captured significant demand?

Device manufacturing sub-services captured more market share than other services. Due to the lack of in-house manufacturing units, there is utmost demand for the manufacturing of medical devices. The medical device segment is segregated into cardiology, orthopedic, general and plastic surgery, drug delivery, dental, endoscopy, diabetes care, ophthalmic, diagnostic imaging, and other areas. Cardiological devices have high demand due to the rapid surge of cardiovascular diseases in old age people.

How Has COVID-19 Impacted Healthcare Contract Development and Manufacturing Organization market?

The COVID-19 pandemic has significantly impacted every industry in the world. However, the Healthcare Contract Development and Manufacturing Organization (CDMO) observed positive growth during the pandemic. Contract manufacturing met the essential needs of the pharmaceutical industries and others during the pandemic. During the pandemic, CDMO provided pharma, biotech, and other companies with time-saving, cost-effective services. The surge in demand for COVID -19 essential vaccines and drugs led to the growth of the healthcare CDMO market during the pandemic.

Competitive Analysis

Some of the key companies in the healthcare CDMO Market include Catalent Inc., Lonza Group Ltd., Recipharm AB, Siegfried Holding AG, and Thermo Fisher Scientific Inc.

Some of the recent developments in the Healthcare Contract Development and Manufacturing Organization market are:

  • In May 2019, Catalent Inc. acquired Paragon Bioservices Inc. for US$ 1.2 Bn. This acquisition will enable Catalent to gain a US$ 40 Bn addressable market for gene therapies.
  • In February 2022, Recipharm acquired Vibalogics, Arranta Bio, and Recipharm’s advanced therapy medicinal products offerings into virotherapy and its biologics offerings in the U.S.
  • In February 2022, Pharma Nobis, LLC completed the acquisition of Fagron’s contract manufacturing business and manufacturing facility.
  • In February 2022, Cytiva and NecstGen collaborated on the development of cell and gene therapies.
  • In February 2022, Australia's Beroni Group opened its first R&D facility in China.

Market Segments Covered in Healthcare CDMO Industry Analysis

By Services

  • Contract Development
    • Small Molecule
    • Large Molecule
    • Shockwave Therapy
  • Contract Manufacturing
    • Small Molecule
    • Large Molecule
    • High Potency API
    • Finished Dose Formulations
    • Medical Devices

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Global Market Snapshot

Attribute

Details

Global Healthcare CDMO Market (2022)

US$ 243.9 Bn

Global Healthcare CDMO Industry (2032)

US$ 723.6 Bn

Global Market CAGR (2022 – 2032)

11.6%

U.S. Healthcare CDMO Market (2022)

US$ 85 Bn

Key Companies Profiled

  • Catalent Inc.
  • Lonza Group Ltd.
  • Recipharm AB
  • Siegfried Holding AG
  • Thermo Fisher Scientific Inc.
  • Covance Inc.
  • Jabil
  • Sanmina Corporation
  • IQVIA Holdings Inc.
  • Flex

Frequently Asked Questions

How much is the current worth of the Healthcare Contract Development and Manufacturing Organization market?

The global Healthcare Contract Development and Manufacturing Organization (CDMO) market is worth more than US$ 243.9 Bn at present.

What is the sales forecast for Healthcare Contract Development and Manufacturing Organization market?

The value of the Healthcare CDMO market is projected to increase at a CAGR of around 11.6% during 2022 – 2032.

What was the last 5 year’s market CAGR?

The value of Healthcare Contract Development and Manufacturing Organization increased at a CAGR of around 9.8% during 2017 – 2021.

Which are the top 5 countries driving demand for Healthcare Contract Development and Manufacturing Organization?

The top 5 countries driving demand for Healthcare Contract Development and Manufacturing Organization market are the U.S., China, Japan, the UK, and South Korea.

What is the forecast for the market in North America?

Healthcare Contract Development and Manufacturing Organization (CDMO) market in North America will grow at 12.8% CAGR during 2022-2032.

Which is the top country for Healthcare Contract Development and Manufacturing Organizations?

The US market for Healthcare Contract Development and Manufacturing Organization is accumulated larger market share and will expand at a CAGR of around 12.6% during 2022 – 2032.

Who are the key players for Healthcare Contract Development and Manufacturing Organization?

The major players are Catalent Inc., Lonza Group Ltd., Recipharm AB, Siegfried Holding AG, and Thermo Fisher Scientific Inc.

    1. Executive Summary

        1.1. Global Market Outlook

        1.2. Summary of Statistics

        1.3. Key Market Characteristics & Attributes

        1.4. Analysis and Recommendations

    2. Market Overview

        2.1. Market Coverage / Taxonomy

        2.2. Market Definition / Scope / Limitations

    3. Market Risks and Trends Assessment

        3.1. Risk Assessment

            3.1.1. COVID-19 Crisis and Impact on Healthcare Contract Development And Manufacturing Organization Demand

            3.1.2. COVID-19 Impact Benchmark with Previous Crisis

            3.1.3. Impact on Market Value (US$ Mn)

            3.1.4. Assessment by Key Countries

            3.1.5. Assessment by Key Market Segments

            3.1.6. Action Points and Recommendation for Suppliers

        3.2. Key Trends Impacting the Market

        3.3. Formulation and Product Development Trends

    4. Market Background and Foundation Data Points

        4.1. Global Healthcare Contract Development And Manufacturing Organization Market (US$ Mn)

        4.2. Healthcare Contract Development And Manufacturing Organization Market Opportunity Assessment (US$ Mn)

            4.2.1. Total Available Market

            4.2.2. Serviceable Addressable Market

            4.2.3. Serviceable Obtainable Market

        4.3. Market Scenario Forecast

            4.3.1. Demand in optimistic Scenario

            4.3.2. Demand in Likely Scenario

            4.3.3. Demand in Conservative Scenario

        4.4. Investment Feasibility Analysis

            4.4.1. Investment in Established Markets

                4.4.1.1. In Short Term

                4.4.1.2. In Long Term

            4.4.2. Investment in Emerging Markets

                4.4.2.1. In Short Term

                4.4.2.2. In Long Term

        4.5. Forecast Factors - Relevance & Impact

            4.5.1. Top Companies Historical Growth

            4.5.2. Global Healthcare Contract Development And Manufacturing Organization Market Growth

            4.5.3. Healthcare Contract Development And Manufacturing Organization Adoption Rate, by Country

        4.6. Market Dynamics

            4.6.1. Market Driving Factors and Impact Assessment

            4.6.2. Prominent Market Challenges and Impact Assessment

            4.6.3. Healthcare Contract Development And Manufacturing Organization Market Opportunities

            4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

    5. Key Success Factors

        5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

        5.2. Banking on with Segments High Incremental Opportunity

        5.3. Peer Benchmarking

    6. Global Healthcare Contract Development And Manufacturing Organization Market Demand Analysis 2017-2021 and Forecast, 2022-2032

        6.1. Historical Market Analysis, 2017-2021

        6.2. Current and Future Market Projections, 2022-2032

        6.3. Y-o-Y Growth Trend Analysis

    7. Global Healthcare Contract Development And Manufacturing Organization Market Value Analysis 2017-2021 and Forecast, 2022-2032

        7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021

        7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

            7.2.1. Y-o-Y Growth Trend Analysis

            7.2.2. Absolute $ Opportunity Analysis

    8. Global Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032, By Services

        8.1. Introduction / Key Findings

        8.2. Historical Market Size (US$ Mn) Analysis By Services , 2017-2021

        8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Services , 2022-2032

            8.3.1. Contract Development

                8.3.1.1. Small Molecule

                8.3.1.2. Large Molecule

                8.3.1.3. Shockwave Therapy

            8.3.2. Contract Manufacturing

                8.3.2.1. Small Molecule

                8.3.2.2. Large Molecule

                8.3.2.3. High Potency API

                8.3.2.4. Finished Dose Formulations

                8.3.2.5. Medical Devices

        8.4. Market Attractiveness Analysis By Services

    9. Global Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032, By Region

        9.1. Introduction

        9.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021

        9.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

            9.3.1. North America

            9.3.2. Latin America

            9.3.3. Europe

            9.3.4. Asia Pacific

            9.3.5. Middle East and Africa (MEA)

        9.4. Market Attractiveness Analysis By Region

    10. North America Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032

        10.1. Introduction

        10.2. Pricing Analysis

        10.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

        10.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

            10.4.1. By Country

                10.4.1.1. U.S.

                10.4.1.2. Canada

            10.4.2. By Services

        10.5. Market Attractiveness Analysis

            10.5.1. By Country

            10.5.2. By Services

    11. Latin America Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032

        11.1. Introduction

        11.2. Pricing Analysis

        11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

        11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

            11.4.1. By Country

                11.4.1.1. Brazil

                11.4.1.2. Mexico

                11.4.1.3. Rest of Latin America

            11.4.2. By Services

        11.5. Market Attractiveness Analysis

            11.5.1. By Country

            11.5.2. By Services

    12. Europe Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032

        12.1. Introduction

        12.2. Pricing Analysis

        12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

        12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

            12.4.1. By Country

                12.4.1.1. Germany

                12.4.1.2. France

                12.4.1.3. U.K.

                12.4.1.4. Italy

                12.4.1.5. Benelux

                12.4.1.6. Nordic Countries

                12.4.1.7. Rest of Europe

            12.4.2. By Services

        12.5. Market Attractiveness Analysis

            12.5.1. By Country

            12.5.2. By Services

    13. Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032

        13.1. Introduction

        13.2. Pricing Analysis

        13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

        13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

            13.4.1. By Country

                13.4.1.1. China

                13.4.1.2. Japan

                13.4.1.3. South Korea

                13.4.1.4. Rest of Asia Pacific

            13.4.2. By Services

        13.5. Market Attractiveness Analysis

            13.5.1. By Country

            13.5.2. By Services

    14. Middle East and Africa Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032

        14.1. Introduction

        14.2. Pricing Analysis

        14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

        14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

            14.4.1. By Country

                14.4.1.1. GCC Countries

                14.4.1.2. South Africa

                14.4.1.3. Turkey

                14.4.1.4. Rest of Middle East and Africa

            14.4.2. By Services

        14.5. Market Attractiveness Analysis

            14.5.1. By Country

            14.5.2. By Services

    15. Key Countries Healthcare Contract Development And Manufacturing Organization Market Analysis 2017-2021 and Forecast 2022-2032

        15.1. Introduction

            15.1.1. Market Value Proportion Analysis, By Key Countries

            15.1.2. Global Vs. Country Growth Comparison

        15.2. US Healthcare Contract Development And Manufacturing Organization Market Analysis

            15.2.1. Value Proportion Analysis by Market Taxonomy

            15.2.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

                15.2.2.1. By Services

        15.3. Canada Healthcare Contract Development And Manufacturing Organization Market Analysis

            15.3.1. Value Proportion Analysis by Market Taxonomy

            15.3.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

                15.3.2.1. By Services

        15.4. Mexico Healthcare Contract Development And Manufacturing Organization Market Analysis

            15.4.1. Value Proportion Analysis by Market Taxonomy

            15.4.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

                15.4.2.1. By Services

        15.5. Brazil Healthcare Contract Development And Manufacturing Organization Market Analysis

            15.5.1. Value Proportion Analysis by Market Taxonomy

            15.5.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

                15.5.2.1. By Services

        15.6. Germany Healthcare Contract Development And Manufacturing Organization Market Analysis

            15.6.1. Value Proportion Analysis by Market Taxonomy

            15.6.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

                15.6.2.1. By Services

        15.7. France Healthcare Contract Development And Manufacturing Organization Market Analysis

            15.7.1. Value Proportion Analysis by Market Taxonomy

            15.7.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

                15.7.2.1. By Services

        15.8. Italy Healthcare Contract Development And Manufacturing Organization Market Analysis

            15.8.1. Value Proportion Analysis by Market Taxonomy

            15.8.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

                15.8.2.1. By Services

        15.9. BENELUX Healthcare Contract Development And Manufacturing Organization Market Analysis

            15.9.1. Value Proportion Analysis by Market Taxonomy

            15.9.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

                15.9.2.1. By Services

        15.10. UK Healthcare Contract Development And Manufacturing Organization Market Analysis

            15.10.1. Value Proportion Analysis by Market Taxonomy

            15.10.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

                15.10.2.1. By Services

        15.11. Nordic Countries Healthcare Contract Development And Manufacturing Organization Market Analysis

            15.11.1. Value Proportion Analysis by Market Taxonomy

            15.11.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

                15.11.2.1. By Services

        15.12. China Healthcare Contract Development And Manufacturing Organization Market Analysis

            15.12.1. Value Proportion Analysis by Market Taxonomy

            15.12.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

                15.12.2.1. By Services

        15.13. Japan Healthcare Contract Development And Manufacturing Organization Market Analysis

            15.13.1. Value Proportion Analysis by Market Taxonomy

            15.13.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

                15.13.2.1. By Services

        15.14. South Korea Healthcare Contract Development And Manufacturing Organization Market Analysis

            15.14.1. Value Proportion Analysis by Market Taxonomy

            15.14.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

                15.14.2.1. By Services

        15.15. GCC Countries Healthcare Contract Development And Manufacturing Organization Market Analysis

            15.15.1. Value Proportion Analysis by Market Taxonomy

            15.15.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

                15.15.2.1. By Services

        15.16. South Africa Healthcare Contract Development And Manufacturing Organization Market Analysis

            15.16.1. Value Proportion Analysis by Market Taxonomy

            15.16.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

                15.16.2.1. By Services

        15.17. Turkey Healthcare Contract Development And Manufacturing Organization Market Analysis

            15.17.1. Value Proportion Analysis by Market Taxonomy

            15.17.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032

                15.17.2.1. By Services

            15.17.3. Competition Landscape and Player Concentration in the Country

    16. Market Structure Analysis

        16.1. Market Analysis by Tier of Companies

        16.2. Market Concentration

        16.3. Market Share Analysis of Top Players

        16.4. Market Presence Analysis

            16.4.1. By Regional footprint of Players

            16.4.2. Product footprint by Players

    17. Competition Analysis

        17.1. Competition Dashboard

        17.2. Competition Benchmarking

        17.3. Competition Deep Dive

            17.3.1. Catalent Inc.

                17.3.1.1. Overview

                17.3.1.2. Product Portfolio

                17.3.1.3. Sales Footprint

                17.3.1.4. Strategy Overview

            17.3.2. Lonza Group Ltd.

                17.3.2.1. Overview

                17.3.2.2. Product Portfolio

                17.3.2.3. Sales Footprint

                17.3.2.4. Strategy Overview

            17.3.3. Recipharm AB

                17.3.3.1. Overview

                17.3.3.2. Product Portfolio

                17.3.3.3. Sales Footprint

                17.3.3.4. Strategy Overview

            17.3.4. Siegfried Holding AG

                17.3.4.1. Overview

                17.3.4.2. Product Portfolio

                17.3.4.3. Sales Footprint

                17.3.4.4. Strategy Overview

            17.3.5. Thermo Fisher Scientific Inc.

                17.3.5.1. Overview

                17.3.5.2. Product Portfolio

                17.3.5.3. Sales Footprint

                17.3.5.4. Strategy Overview

            17.3.6. Covance Inc.

                17.3.6.1. Overview

                17.3.6.2. Product Portfolio

                17.3.6.3. Sales Footprint

                17.3.6.4. Strategy Overview

            17.3.7. Jabil

                17.3.7.1. Overview

                17.3.7.2. Product Portfolio

                17.3.7.3. Sales Footprint

                17.3.7.4. Strategy Overview

            17.3.8. Sanmina Corporation

                17.3.8.1. Overview

                17.3.8.2. Product Portfolio

                17.3.8.3. Sales Footprint

                17.3.8.4. Strategy Overview

            17.3.9. IQVIA Holdings Inc.

                17.3.9.1. Overview

                17.3.9.2. Product Portfolio

                17.3.9.3. Sales Footprint

                17.3.9.4. Strategy Overview

            17.3.10. Flex

                17.3.10.1. Overview

                17.3.10.2. Product Portfolio

                17.3.10.3. Sales Footprint

                17.3.10.4. Strategy Overview

    18. Assumptions and Acronyms Used

    19. Research Methodology

    List of Tables

    Table 1: Global Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2017 – 2021

    Table 2: Global Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2022 – 2032

    Table 3: Global Healthcare Contract Development And Manufacturing Organization Market, By Region, 2017 – 2021

    Table 4: Global Healthcare Contract Development And Manufacturing Organization Market, By Region, 2022 – 2032

    Table 5: North America Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2017 – 2021

    Table 6: North America Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2022 – 2032

    Table 7: North America Healthcare Contract Development And Manufacturing Organization Market, By Country, 2017 – 2021

    Table 8: North America Healthcare Contract Development And Manufacturing Organization Market, By Country, 2022 – 2032

    Table 9: Latin America Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2017 – 2021

    Table 10: Latin America Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2022 – 2032

    Table 11: Latin America Healthcare Contract Development And Manufacturing Organization Market, By Country, 2017 – 2021

    Table 12: Latin America Healthcare Contract Development And Manufacturing Organization Market, By Country, 2022 – 2032

    Table 13: Europe Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2017 – 2021

    Table 14: Europe Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2022 – 2032

    Table 15: Europe Healthcare Contract Development And Manufacturing Organization Market, By Country, 2017 – 2021

    Table 16: Europe Healthcare Contract Development And Manufacturing Organization Market, By Country, 2022 – 2032

    Table 17: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2017 – 2021

    Table 18: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2022 – 2032

    Table 19: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market, By Country, 2017 – 2021

    Table 20: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market, By Country, 2022 – 2032

    Table 21: MEA Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2017 – 2021

    Table 22: MEA Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn), By Services , 2022 – 2032

    Table 23: MEA Healthcare Contract Development And Manufacturing Organization Market, By Country, 2017 – 2021

    Table 24: MEA Healthcare Contract Development And Manufacturing Organization Market, By Country, 2022 – 2032

    Table 25: Global Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Services , 2017 - 2021

    Table 26: Global Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Region, 2022 – 2032

    Table 27: North America Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Services , 2017 - 2021

    Table 28: North America Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Country, 2022 – 2032

    Table 29: Latin America Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Services , 2017 - 2021

    Table 30: Latin America Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Country, 2022 – 2032

    Table 31: Europe Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Services , 2017 - 2021

    Table 32: Europe Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Country, 2022 - 2032

    Table 33: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Services , 2017 - 2021

    Table 34: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Country, 2022 – 2032

    Table 35: MEA Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Services , 2017 - 2021

    Table 36: MEA Healthcare Contract Development And Manufacturing Organization Market Incremental $ Opportunity, By Country, 2022 - 2032

    List of Figures

    Figure 1: Global Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032

    Figure 2: Global Healthcare Contract Development And Manufacturing Organization Market Absolute $ Historical Gain (2017 - 2021) and Opportunity (2022 – 2032), US$ Mn

    Figure 3: Global Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2022 & 2032

    Figure 4: Global Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Services – 2022-2032

    Figure 5: Global Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Services – 2022-2032

    Figure 6: Global Healthcare Contract Development And Manufacturing Organization Market Share, By Region, 2022 & 2032

    Figure 7: Global Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Region – 2022-2032

    Figure 8: Global Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Region – 2022-2032

    Figure 9: North America Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032

    Figure 10: North America Healthcare Contract Development And Manufacturing Organization Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn

    Figure 11: North America Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2022 & 2032

    Figure 12: North America Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Services – 2022-2032

    Figure 13: North America Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Services – 2022-2032

    Figure 14: North America Healthcare Contract Development And Manufacturing Organization Market Share, By Country, 2022 & 2032

    Figure 15: North America Market Y-o-Y Growth Projections, By Country – 2022-2032

    Figure 16: North America Market Attractiveness Index, By Country – 2022-2032

    Figure 17: Latin America Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032

    Figure 18: Latin America Healthcare Contract Development And Manufacturing Organization Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn

    Figure 19: Latin America Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2022 & 2032

    Figure 20: Latin America Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Services – 2022-2032

    Figure 21: Latin America Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Services – 2022-2032

    Figure 22: Latin America Healthcare Contract Development And Manufacturing Organization Market Share, By Country, 2022 & 2032

    Figure 23: Latin America Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Country – 2022-2032

    Figure 24: Latin America Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Country – 2022-2032

    Figure 25: Europe Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032

    Figure 26: Europe Healthcare Contract Development And Manufacturing Organization Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn

    Figure 27: Europe Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2022 & 2032

    Figure 28: Europe Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Services – 2022-2032

    Figure 29: Europe Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Services – 2022-2032

    Figure 30: Europe Healthcare Contract Development And Manufacturing Organization Market Share, By Country, 2022 & 2032

    Figure 31: Europe Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Country – 2022-2032

    Figure 32: Europe Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Country – 2022-2032

    Figure 33: MEA Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032

    Figure 34: MEA Healthcare Contract Development And Manufacturing Organization Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn

    Figure 35: MEA Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2022 & 2032

    Figure 36: MEA Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Services  – 2022-2032

    Figure 37: MEA Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Services  – 2022-2032

    Figure 38: MEA Healthcare Contract Development And Manufacturing Organization Market Share, By Country, 2022 & 2032

    Figure 39: MEA Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Country – 2022-2032

    Figure 40: MEA Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Country – 2022-2032

    Figure 41: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Year-on-Year Growth, 2017-2032

    Figure 42: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$ Mn

    Figure 43: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2022 & 2032

    Figure 44: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Services – 2022-2032

    Figure 45: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Services – 2022-2032

    Figure 46: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Share, By Country, 2022 & 2032

    Figure 47: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Y-o-Y Growth Projections, By Country – 2022-2032

    Figure 48: Asia Pacific Healthcare Contract Development And Manufacturing Organization Market Attractiveness Index, By Country – 2022-2032

    Figure 49: US Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

    Figure 50: US Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

    Figure 51: Canada Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

    Figure 52: Canada Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

    Figure 53: Brazil Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

    Figure 54: Brazil Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

    Figure 55: Mexico Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

    Figure 56: Mexico Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

    Figure 57: Germany Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

    Figure 58: Germany Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

    Figure 59: U.K. Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

    Figure 60: U.K. Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

    Figure 61: France Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

    Figure 62: France Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

    Figure 63: Italy Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

    Figure 64: Italy Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

    Figure 65: BENELUX Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

    Figure 66: BENELUX Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

    Figure 67: Nordic Countries Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

    Figure 68: Nordic Countries Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

    Figure 69: China Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

    Figure 70: China Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

    Figure 71: Japan Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

    Figure 72: Japan Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

    Figure 73: South Korea Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

    Figure 74: South Korea Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

    Figure 75: GCC Countries Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

    Figure 76: GCC Countries Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

    Figure 77: South Africa Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

    Figure 78: South Africa Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

    Figure 79: Turkey Healthcare Contract Development And Manufacturing Organization Market Value (US$ Mn) and Forecast, 2022 - 2032

    Figure 80: Turkey Healthcare Contract Development And Manufacturing Organization Market Share, By Services , 2021

Copyright © Transparency Market Research, Inc. All Rights reserved